Healthcare provider profile · identity verified

Walid Omar, MD

Family Practice · ST AUGUSTINE, FL · NPI 1063466845

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	151	53
Levothyroxine Sodium	Levothyroxine Sodium	142	41
Rosuvastatin Calcium	Rosuvastatin Calcium	130	44
Metformin Hcl	Metformin Hcl	95	34
Lisinopril	Lisinopril	94	32
Mirtazapine	Mirtazapine	88	35
Amlodipine Besylate	Amlodipine Besylate	75	24
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	73	suppressed
Ozempic	Semaglutide	73	22
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	69	13
Carvedilol	Carvedilol	65	23
Lorazepam	Lorazepam	64	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	64	22
Furosemide	Furosemide	63	28
Meloxicam	Meloxicam	60	23
Omeprazole	Omeprazole	59	21
Trazodone Hcl	Trazodone Hcl	59	20
Albuterol Sulfate Hfa	Albuterol Sulfate	51	15
Potassium Chloride	Potassium Chloride	50	18
Sertraline Hcl	Sertraline Hcl	49	14
Losartan Potassium	Losartan Potassium	48	16
Clonazepam	Clonazepam	47	suppressed
Azithromycin	Azithromycin	46	39
Metoprolol Tartrate	Metoprolol Tartrate	45	16
Alprazolam	Alprazolam	44	suppressed
Fluticasone Propionate	Fluticasone Propionate	43	22
Prednisone	Prednisone	43	29
Cefdinir	Cefdinir	42	25
Gabapentin	Gabapentin	42	23
Metoprolol Succinate	Metoprolol Succinate	42	12
Alendronate Sodium	Alendronate Sodium	40	11
Pantoprazole Sodium	Pantoprazole Sodium	38	21
Montelukast Sodium	Montelukast Sodium	34	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	31	suppressed
Duloxetine Hcl	Duloxetine Hcl	31	suppressed
Mounjaro	Tirzepatide	31	suppressed
Clopidogrel	Clopidogrel Bisulfate	30	suppressed
Divalproex Sodium Er	Divalproex Sodium	29	suppressed
Invega Sustenna	Paliperidone Palmitate	29	suppressed
Eliquis	Apixaban	28	suppressed
Lamotrigine	Lamotrigine	28	suppressed
Divalproex Sodium	Divalproex Sodium	26	suppressed
Celecoxib	Celecoxib	25	suppressed
Nifedipine Er	Nifedipine	25	suppressed
Allopurinol	Allopurinol	24	suppressed
Bupropion Hcl	Bupropion Hcl	24	suppressed
Finasteride	Finasteride	24	suppressed
Levofloxacin	Levofloxacin	24	19
Donepezil Hcl	Donepezil Hcl	23	suppressed
Testosterone Cypionate	Testosterone Cypionate	22	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	21	suppressed
Hydrocortisone	Hydrocortisone	21	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Diclofenac Sodium	Diclofenac Sodium	19	suppressed
Risperidone	Risperidone	19	suppressed
Simvastatin	Simvastatin	19	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	19	suppressed
Famotidine	Famotidine	18	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	18	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Pregabalin	Pregabalin	18	suppressed
Bumetanide	Bumetanide	17	suppressed
Megestrol Acetate	Megestrol Acetate	17	suppressed
Tradjenta	Linagliptin	17	suppressed
Citalopram Hbr	Citalopram Hydrobromide	16	suppressed
Nystatin	Nystatin	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Glipizide	Glipizide	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Tramadol Hcl	Tramadol Hcl	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Pravastatin Sodium	Pravastatin Sodium	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Baclofen	Baclofen	12	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	11
Entresto	Sacubitril/Valsartan	12	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error